General Information of the Compound
| Compound ID |
CP0019844
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
7-methoxy-1-methyl-9H-beta-carboline;hydrochloride
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-Methyl-7-methoxy-beta-carboline
442-51-3
4FHH5G48T7
7-METHOXY-1-METHYL-9H-BETA-CARBOLINE
7-Methoxy-1-methyl-9H-beta-carboline
7-Methoxy-1-methyl-9H-pyrido(3,4-b)indole
7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole
9H-Pyrido(3,4-b)indole, 7-methoxy-1-methyl-
9H-Pyrido[3,4-b]indole, 7-methoxy-1-methyl-
BRN 0178813
Banisterin
Banisterine
Banisterine monohydrate
C13H12N2O
CHEBI:28121
EINECS 207-131-4
Harmin
Harmin hydrochloride
Harmine
Harmine, 98%
Leucoharmine
Telepathin
Telepathine
UNII-4FHH5G48T7
Yagein
Yageine
Yajeine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C13H12N2O
|
||||||||||||||||||
| Molecular Weight |
212.252
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc2c(c1)[nH]c1c(C)nccc21
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H12N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-7,15H,1-2H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
BXNJHAXVSOCGBA-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
442-51-3
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02718, Broad substrate specificity ATP-binding cassette transporter ABCG2
Protein ID: PT01592, Dual specificity tyrosine-phosphorylation-regulated kinase 1A
Protein ID: PT00962, Glycogen synthase kinase-3 beta
Clinical Information about the Compound
Drug 1 ( Harmine )
| Drug Name | Harmine | ||
|---|---|---|---|
| Target(s) |
Monoamine oxidase type A (MAO-A)
Inhibitor
|
||